Note: Ingredients listed on restricted chemical lists
EC/CAS
9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
>=60-<80
EC/CAS
202-966-0/101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
>=40-<60
General Information
Version
1.0
Revision date
2026-03-03
Product name
Ucrete PT2 Common Part 2
1.2.1 Relevant identified uses
Flooring system
supplier name
Sika Srbija d.o.o
Emergency telephone
+381 22 21 55 777, +381 22 21 55 780, +381 11 360 84 40
Icons in SDS
Company Information
company name
Sika Srbija d.o.o
e-mail address of the competent person responsible for the Safety Data Sheet
ehs@rs.sika.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H332, H334, H335, H351, H373
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Type of product Mixture Classification of the substance or mixture Classification (according to regulation governing the classification, packaging and label- ing of chemicals) Acute toxicity, Category 4 H332: Harmful if inhaled Skin irritation, Category 2 H315: Causes skin irritation Eye irritation, Category 2 H319: Causes serious eye irritation Respiratory sensitisation, Category 1 H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled Skin sensitisation, Category 1 H317: May cause an allergic skin reaction Carcinogenicity, Category 2 H351: Suspected of causing cancer Specific target organ toxicity - single ex- H335: May cause respiratory irritation posure, Category 3, Respiratory system Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2 longed or repeated exposure if inhaled
2.2 Label elements
Labelling (according to regulation governing the classification, packaging and labeling of chemicals)
Signal word
Danger
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H332 Harmful if inhaled. H334 May cause allergy or asthma symptoms or breath- ing difficulties if inhaled. H335 May cause respiratory irritation. H351 Suspected of causing cancer. H373 May cause damage to organs through prolonged or repeated exposure if inhaled.
Prevention
P201 Obtain special instructions before use. P260 Do not breathe mist or vapours. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.
Hazardous Ingredients
Diphenylmethanediisocyanate, isomeres and homologues 4,4'-methylenediphenyl diisocyanate
Additional information
"As from 24 August 2023 adequate training is required before industrial or pro- fessional use."
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. None known.
2.1 Classification of the substance or mixture
Classification (according to regulation governing the classification, packaging and label- ing of chemicals) Acute toxicity, Category 4 H332: Harmful if inhaled. Skin irritation, Category 2 H315: Causes skin irritation. Eye irritation, Category 2 H319: Causes serious eye irritation. Respiratory sensitisation, Category 1 H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Carcinogenicity, Category 2 H351: Suspected of causing cancer. Specific target organ toxicity - single ex- H335: May cause respiratory irritation. posure, Category 3, Respiratory system Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2 longed or repeated exposure if inhaled.
